SBI Healthcare Opportunities Fund - Growth - Direct Plan

Other Plans and Options
  • 0.03 %Nav, as on 05-09-2025

  • Previous Nav

  • Net Change on 05-09-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH -0.43 3.74 6.12 27.93 22.27 18.09
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
BSE SENSEX - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 6.12 27.93 22.27 0.91 4,026.55
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 0.08 24.47 20.18 0.89 8,736.57
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 4.69 29.61 22.61 1.04 6,103.96
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 -0.43 26.28 20.43 0.56 3,190.15
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 0.88 23.51 20.63 0.48 2,908.21
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 0.67 25.86 21.12 0.61 1,339

Fund Holdings as on 31-July-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • Cipla Ltd.

  • Lonza Group

  • Lupin Ltd.

  • Gland Pharma Ltd.

  • Mankind Pharma Ltd.

  • Acutaas Chemicals Ltd.

  • Krishna Institute of Medical Sciences Ltd.

  • Fortis Healthcare Ltd.

  • Biocon Ltd.

  • Abbott India Ltd.

  • Laurus Labs Ltd.

  • Aster DM Healthcare Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Concord Biotech Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • TREPS

  • Polymedicure Ltd.

  • Aether Industries Ltd.

  • Alkem Laboratories Ltd.

  • Anthem Biosciences Ltd.

  • Rainbow Children's Medicare Ltd.

  • Aurobindo Pharma Ltd.

  • Cohance Lifesciences Ltd.

  • Vijaya Diagnostic Centre Ltd.

  • Pfizer Ltd.

  • Akums Drugs & Pharmaceuticals Ltd.

  • Gufic Biosciences Ltd.

  • Sanofi Consumer Healthcare India Ltd.

  • 182 DAY T-BILL 20.11.25

  • Net Receivable / Payable

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Chemicals

View More

Fund Manager

  • Cash

  • Equity

  • Sovereign

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 01-Jan-2013 and currently has an AUM of ₹4,026.55 crore. SBI Healthcare Opportunities Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended up ₹0.14(0.03%)yesterday to ₹496.0496.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .

Fund House Contact

9th Floor, Crescenzo, C - 38 & 39 G Block, BKC, Bandra (East) Mumbai - 400 051

022 - 61793537
022 - 22189663
www.sbimf.com